These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26802601)

  • 1. CCL2 gene polymorphism is associated with post-transplant diabetes mellitus.
    Dabrowska-Zamojcin E; Romanowski M; Dziedziejko V; Maciejewska-Karlowska A; Sawczuk M; Safranow K; Domanski L; Pawlik A
    Int Immunopharmacol; 2016 Mar; 32():62-65. PubMed ID: 26802601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adiponectin and leptin gene polymorphisms in patients with post-transplant diabetes mellitus.
    Romanowski M; Dziedziejko V; Maciejewska-Karlowska A; Sawczuk M; Safranow K; Domanski L; Pawlik A
    Pharmacogenomics; 2015; 16(11):1243-51. PubMed ID: 26282401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic risk factors for post-transplantation diabetes mellitus in Chinese Han renal allograft recipients treated with tacrolimus.
    Zhang X; Men T; Liu H; Li X; Wang J; Lv J
    Transpl Immunol; 2018 Aug; 49():39-42. PubMed ID: 29665413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of tacrolimus and the development of posttransplant diabetes mellitus: a Brazilian single-center, observational study.
    Gnatta D; Keitel E; Heineck I; Cardoso BD; Rodrigues AP; Michel K; Garcia VD
    Transplant Proc; 2010 Mar; 42(2):475-8. PubMed ID: 20304169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttransplant diabetes mellitus in kidney transplant recipients receiving calcineurin or mTOR inhibitor drugs.
    Araki M; Flechner SM; Ismail HR; Flechner LM; Zhou L; Derweesh IH; Goldfarb D; Modlin C; Novick AC; Faiman C
    Transplantation; 2006 Feb; 81(3):335-41. PubMed ID: 16477217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and genetic risk factors for new-onset diabetes mellitus after transplantation (NODAT) in major transplant centres in Malaysia.
    Guad RM; Taylor-Robinson AW; Wu YS; Gan SH; Zaharan NL; Basu RC; Liew CSL; Wan Md Adnan WAH
    BMC Nephrol; 2020 Sep; 21(1):388. PubMed ID: 32894076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CCL2, CCL5, IL4 and IL15 Gene Polymorphisms in Women with Gestational Diabetes Mellitus.
    Teler J; Tarnowski M; Safranow K; Maciejewska A; Sawczuk M; Dziedziejko V; Sluczanowska-Glabowska S; Pawlik A
    Horm Metab Res; 2017 Jan; 49(1):10-15. PubMed ID: 27472286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significant associations between CCL5 gene polymorphisms and post-transplantational diabetes mellitus in Korean renal allograft recipients.
    Jeong KH; Moon JY; Chung JH; Kim YH; Lee TW
    Am J Nephrol; 2010; 32(4):356-61. PubMed ID: 20805685
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transplant diabetes mellitus: is it associated with poor allograft outcomes in renal transplants?
    Choi JY; Kwon OJ
    Transplant Proc; 2013 Oct; 45(8):2892-8. PubMed ID: 24156999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacogenetics of post-transplant diabetes mellitus in children with renal transplantation treated with tacrolimus.
    Lancia P; Adam de Beaumais T; Elie V; Garaix F; Fila M; Nobili F; Ranchin B; Testevuide P; Ulinski T; Zhao W; Deschênes G; Jacqz-Aigrain E
    Pediatr Nephrol; 2018 Jun; 33(6):1045-1055. PubMed ID: 29399716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum magnesium, hepatocyte nuclear factor 1β genotype and post-transplant diabetes mellitus: a prospective study.
    van der Burgh AC; Moes A; Kieboom BCT; van Gelder T; Zietse R; van Schaik RHN; Hesselink DA; Hoorn EJ
    Nephrol Dial Transplant; 2020 Jan; 35(1):176-183. PubMed ID: 31361318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients.
    Numakura K; Satoh S; Tsuchiya N; Horikawa Y; Inoue T; Kakinuma H; Togashi H; Matsuura S; Tada H; Suzuki T; Habuchi T
    Transplant Proc; 2005 May; 37(4):1865-7. PubMed ID: 15919487
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The incidence of posttransplantation diabetes mellitus during follow-up in kidney transplant recipients and relationship to Fok1 vitamin D receptor polymorphism.
    Yao B; Chen X; Shen FX; Xu W; Dong TT; Chen LZ; Weng JP
    Transplant Proc; 2013; 45(1):194-6. PubMed ID: 23375298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensinogen polymorphisms and post-transplantation diabetes mellitus in Korean renal transplant subjects.
    Lee Sr; Moon JY; Lee SH; Ihm CG; Lee TW; Kim SK; Chung JH; Kang SW; Kim TH; Park SJ; Kim YH; Jeong KH
    Kidney Blood Press Res; 2013; 37(2-3):95-102. PubMed ID: 23594830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Post-transplant diabetes mellitus: increasing incidence in renal allograft recipients transplanted in recent years.
    Cosio FG; Pesavento TE; Osei K; Henry ML; Ferguson RM
    Kidney Int; 2001 Feb; 59(2):732-7. PubMed ID: 11168956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetes mellitus after transplant: relationship to pretransplant glucose metabolism and tacrolimus or cyclosporine A-based therapy.
    Sato T; Inagaki A; Uchida K; Ueki T; Goto N; Matsuoka S; Katayama A; Haba T; Tominaga Y; Okajima Y; Ohta K; Suga H; Taguchi S; Kakiya S; Itatsu T; Kobayashi T; Nakao A
    Transplantation; 2003 Nov; 76(9):1320-6. PubMed ID: 14627910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance in kidney allograft recipients treated with calcineurin inhibitors.
    Wyzgał J; Paczek L; Sańko-Resmer J; Ciszek M; Nowak M; Rowiński W; Szmidt J; Durlik M
    Ann Transplant; 2007; 12(2):26-9. PubMed ID: 18173063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-17 gene polymorphisms in patients with post-transplant diabetes mellitus.
    Romanowski M; Domanski L; Pawlik A; Osekowska B; Dziedziejko V; Safranow K; Ciechanowski K
    Eur Rev Med Pharmacol Sci; 2015 Sep; 19(17):3152-6. PubMed ID: 26400516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Role of TCF7L2 rs7903146 in Diabetes After Kidney Transplant: Results From a Single-Center Cohort and Meta-Analysis of the Literature.
    Quaglia M; Terrazzino S; Musetti C; Cargnin S; Merlotti G; Cena T; Stratta P; Genazzani A
    Transplantation; 2016 Aug; 100(8):1750-8. PubMed ID: 26555947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. KCNJ11 and KCNQ1 Gene Polymorphisms Are Not Associated with Post-Transplant Diabetes Mellitus in Kidney Allograft Recipients Treated with Tacrolimus.
    Dabrowska-Zamojcin E; Tarnowski M; Szydlowski M; Romanowski M; Dziedziejko V; Safranow K; Domanski L; Pawlik A
    Folia Biol (Praha); 2017; 63(3):115-119. PubMed ID: 28805561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.